DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Abciximab
Abciximab
Eptifibatide Is Noninferior to Abciximab: Implications for Clinical Practice
Deliverable 5.A Interim Report on the Study Results APPENDIX 2
Reopro
AHS Provincial High-Alert Medication List
(12) United States Patent (10) Patent No.: US 8,835,407 B2 Mosher Et Al
The Efficacy and Safety of Combination Glycoprotein Iibiiia Inhibitors And
Neuraxial Access Or Peripheral Nerve Procedures)
A Aaas. See Abdominal Aortic Aneurysms Aads. See Adjuvant
Glycoprotein (GP) Iib/Iiia Receptor Inhibitors for Use in Acute Coronary Syndromes (ACS) & Percutaneous Coronary Intervention (PCI)
Protocol for Non-Interventional Studies Based on Existing Data TITLE PAGE Document Number: C30445781-01
Abciximab for Intravenous Administration
Antithrombotic Reversal – Adult – Inpatient Clinical Practice Guideline
A Case of Abciximab Induced Acute Profound Thrombocytopenia Resulting in Compartment Syndrome of the Forearm from Massive Bleeding at the Brachial Artery Access Site
Abciximab (Reopro®)
Acute Profound Thrombocytopenia Following Angioplasty: the Dilemma in the Management and a Review of the Literature
140-239.9 Organ Failure
Xigris, INN-Drotrecogin Alfa (Activated)
Abciximab in the Treatment of Acute Myocardial Infarction Eligible For
Top View
Medication Safety and High Alert Medications Objectives
Summary of Product Characteristics
Reopro Abciximab for Intravenous Administration
Pharmaceutical Compositions Comprising Prasugrel And
ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
Antithrombotic Effects of Abciximab
Effectiveness of Tirofiban, Eptifibatide, and Abciximab in Minimizing
Use of Low-Molecular-Weight Heparins in the Management of Acute Coronary Artery Syndromes and Percutaneous Coronary Intervention
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27
ANTICOAGULANT, THROMBOLYTIC, and ANTI-PLATELET DRUGS
Effect of Low-Dose Intracoronary Alteplase During Primary
In Situ Administration of Abciximab for Thrombus Resolution During Intracranial Bypass Surgery: Case Report
Annex I Summary of Product Characteristics
Xigris, INN-Drotrecogin Alfa
2020 Table of Drugs
The Effect of Enoxaparin on in Vitro Stimulated Platelet Aggregation by Elective Percutaneous Coronary Intervention Patients
Occurrence and Clinical Significance of Pseudothrombocytopenia During
Appendix C - Guidelines for IV Medication Administration